4 citations
,
April 2000 in “Plastic and Reconstructive Surgery”
The document suggests fixing common hair transplant issues by combining artistic principles with plug reduction, recycling, and additional micrograft transplantation, while also potentially using arnica to help with post-operative swelling.
The conversation discusses the lack of significant advancements in hair loss treatments beyond finasteride and minoxidil, questioning if hairrestoration technology has reached a dead end. Hair transplant technology has improved, but new medications face challenges with market entry, cost, accessibility, and long-term effectiveness.
The conversation discusses skepticism about a user's hairrestoration progress, with accusations of the post being fake and promoting an AI app. Treatments mentioned include dutasteride and oral minoxidil, with some users discussing side effects and safety of minoxidil.
The individual has experienced no hair regrowth from using minoxidil and finasteride and is considering a hairrestoration clinic's options, including PRP and nano follicle hair replacement, as well as a potential beard transplant. They are seeking advice on whether to pursue PRP, timing for hair replacement surgery, and experiences with beard transplants.
A 35-year-old male shared his hairrestoration journey, starting with minoxidil and finasteride, which improved his hairline and crown, followed by a hair transplant in November 2024. He stopped finasteride to conceive, experienced some shedding, and is now considering switching to dutasteride while continuing minoxidil.
A US federal judge ruled that using patients' stem cells for medical treatments is not under FDA jurisdiction, potentially speeding up development of stem cell-based hair loss therapies. Some users are optimistic about increased research and development, while others express skepticism about the ruling's impact on safety and efficacy standards.